131 related articles for article (PubMed ID: 33785723)
1. Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma.
Yushko LA; Sarnatskaya VV; Sakhno LA; Hudenko NV; Paziuk LM; Maslenny VN; Melnyk VO; Nikolaev VG
Exp Oncol; 2021 Mar; 43(1):21-25. PubMed ID: 33785723
[TBL] [Abstract][Full Text] [Related]
2. Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth.
Sarnatskaya VV; Yushko LA; Prokopenko IV; Hudenko NV; Maslenny VN; Paziuk LM; Bubnovskaya LN; Nikolaev VG
Exp Oncol; 2020 Mar; 42(1):40-45. PubMed ID: 32231185
[TBL] [Abstract][Full Text] [Related]
3. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells.
Boroday NV; Chekhun VF
Exp Oncol; 2018 Mar; 40(1):42-47. PubMed ID: 29600974
[TBL] [Abstract][Full Text] [Related]
4. Effects induced by a 50 Hz electromagnetic field and doxorubicin on Walker-256 carcinosarcoma growth and hepatic redox state in rats.
Orel VE; Krotevych M; Dasyukevich O; Rykhalskyi O; Syvak L; Tsvir H; Tsvir D; Garmanchuk L; Orel VВ; Sheina I; Rybka V; Shults NV; Suzuki YJ; Gychka SG
Electromagn Biol Med; 2021 Oct; 40(4):475-487. PubMed ID: 34392747
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
[TBL] [Abstract][Full Text] [Related]
6. Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats.
Martins GG; Lívero FA; Stolf AM; Kopruszinski CM; Cardoso CC; Beltrame OC; Queiroz-Telles JE; Strapasson RL; Stefanello MÉ; Oude-Elferink R; Acco A
Chem Biol Interact; 2015 Feb; 228():46-56. PubMed ID: 25616030
[TBL] [Abstract][Full Text] [Related]
7. Action of tacrolimus on Wistar rat kidneys implanted with Walker 256 carcinosarcoma.
Inácio CM; Dietz UA; Malafaia O; Ribas Filho JM; Nassif PA; Czeczko NG; Marcondes CA
Acta Cir Bras; 2010 Feb; 25(1):98-104. PubMed ID: 20126896
[TBL] [Abstract][Full Text] [Related]
8. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
9. Total proteolytic activity and content of the main proteinase inhibitors in blood plasma of rats bearing doxorubicin-sensitive and doxorubicin-resistant Guerin carcinoma.
Chekhun VF; Kovtonyuk OV; Todor IN; Kulik GI; Tryndiak VP
Exp Oncol; 2004 Sep; 26(3):232-5. PubMed ID: 15494693
[TBL] [Abstract][Full Text] [Related]
10. [Blood plasma transcortin during growth of Walker carcinosarcoma].
Krauialis KI; Diashrius AP; Ulinskaĭte AP; Kershulis AA
Vopr Onkol; 1980; 26(4):109-11. PubMed ID: 7376540
[No Abstract] [Full Text] [Related]
11. Reduced Walker 256 carcinosarcoma growth in vasopressin-deficient Brattleboro rats.
Khegay II; Popova NA; Ivanova LN
Tumour Biol; 2010 Dec; 31(6):569-73. PubMed ID: 20559788
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural and stereological analysis of walker 256 carcinosarcoma cells at various stages of their differentiation.
Ovsjanko EV; Efremov AV; Michurina SV; Bgatova NP; Lushnikova EL; Ovsjanko YU; Vakulin GM
Bull Exp Biol Med; 2009 Sep; 148(3):447-51. PubMed ID: 20396709
[TBL] [Abstract][Full Text] [Related]
13. The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256.
Minne H; Raue F; Bellwinkel S; Ziegler R
Acta Endocrinol (Copenh); 1975 Mar; 78(3):613-24. PubMed ID: 1173020
[TBL] [Abstract][Full Text] [Related]
14. Enhanced metastasis formation by combined hyperthermia and hyperglycemia in rats bearing Walker 256 carcinosarcoma.
Shah SA; Jain RK; Finney PL
Cancer Lett; 1983 Jul; 19(3):317-23. PubMed ID: 6883314
[TBL] [Abstract][Full Text] [Related]
15. Plasma of Walker-256 carcinosarcoma bearing rats contains parathormone related peptide.
Torres R; Díaz Diego EM; de la Piedra C; Rapado A
Horm Metab Res; 1992 May; 24(5):246-7. PubMed ID: 1398467
[No Abstract] [Full Text] [Related]
16. Dynamics of tumor growth in Brattleboro and WAG rats injected with Walker 256 carcinosarcoma cells in different doses.
Khegay II; Popova NA; Ganilova LS; Shnyder EP; Ivanova LN
Bull Exp Biol Med; 2008 Jan; 145(1):81-3. PubMed ID: 19024010
[TBL] [Abstract][Full Text] [Related]
17. [The evaluation of metastatic damage of the liver of the Wistar rats under conditions of spontaneous development of the Walker 256 carcinosarcoma].
Kunts TA; Efremov AV; Ovsianko EV; Pustovetova MG
Vopr Onkol; 2014; 60(1):80-3. PubMed ID: 24772621
[TBL] [Abstract][Full Text] [Related]
18. Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Torres R; de la Piedra C; Rapado A
Oncology; 1993; 50(2):148-52. PubMed ID: 8451038
[TBL] [Abstract][Full Text] [Related]
19. pH-Sensitive DOX-Loaded PAA-PF127-PAA Micelles Combined with Cryotherapy for Treating Walker 256 Carcinosarcoma in a Rat Model.
Zhao H; Sun S; Wang Z; Hong Y; Shi L; Lan M
J Nanosci Nanotechnol; 2018 Dec; 18(12):8070-8077. PubMed ID: 30189921
[TBL] [Abstract][Full Text] [Related]
20. [Chromatographic transcortin analysis of the blood plasma in tumor-bearing rats].
Krauialis KI; Diashrius AP; Ulinskaĭte AP; Kershulis AA
Vopr Onkol; 1980; 26(9):53-6. PubMed ID: 7423905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
